Longevc
Emerging managerBuilt from this firm's Form D filings. The firm files no SEC adviser report.
- Website
- https://longevc.com
- HQ
- DE
LongeVC is a venture capital firm investing in an ageless future. Its team includes managing partners Garri Zmudze, Ilya Suharenko, and Sergey Jakimov, plus principal Vlad Cernoutan, operating partner Artem Trotsyuk, and venture partners Greg Fishman, Matthew Toner, and Timothy Morris. Its portfolio spans cancer treatments, aging biomarkers, diagnostics, and health testing.
01 · Says / Does
| Tag | Says | Does |
|---|---|---|
| Stages | Not stated | Not enough dated deals |
| Sectors | Not stated | Not enough dated deals |
| Regions | Not stated | Not enough dated deals |
Says: what the firm's funds state. Does: from 0 dated deals in the last 24 months.
02 · Fund history
| Fund | Year | Size | Status |
|---|---|---|---|
| LongeVC Fund II, LP | 2025 | $11.5M (Form D) | Raising |
03 · People across funds
- William Usdin, Manager of the General Partner of the Issuer
LongeVC Fund II, LP (Named on Form D)
- Artem Trotsyuk, Operating Partner - US
LongeVC Fund II, LP (Team)
- Garri Zmudze, Managing Partner
LongeVC Fund II, LP (Team)
- Greg Fishman, Venture Partner
LongeVC Fund II, LP (Team)
- Ilya Suharenko, Managing Partner
LongeVC Fund II, LP (Team)
- Matthew Toner, Venture Partner
LongeVC Fund II, LP (Team)
- Sergey Jakimov, Managing Partner
LongeVC Fund II, LP (Team)
- Timothy Morris, Venture Partner
LongeVC Fund II, LP (Team)
- Vlad Cernoutan, Principal
LongeVC Fund II, LP (Team)
04 · Recent deals
No dated deals found yet.
05 · Latest from the firm
No news from the firm's website yet.
06 · Sources
Fund dates and sizes are from SEC Form D filings.
Last verified: Oct 25, 2026